Since 1975
  • facebook
  • twitter
  • instagram
  • Home
  • Fujifilm’s Avigan flu drug confirmed to work against COVID-19

Fujifilm’s Avigan flu drug confirmed to work against COVID-19

18 Mar 2020
The Avigan influenza drug developed by an affiliate of Japan's Fujifilm Holdings Corp. has been confirmed by clinical tests to be effective in treating patients with COVID-19. (AFP)
The Avigan influenza drug developed by an affiliate of Japan's Fujifilm Holdings Corp. has been confirmed by clinical tests to be effective in treating patients with COVID-19. (AFP)
Short Url:
Updated 18 Mar 2020
18 Mar 2020

BEIJING: The Avigan influenza drug developed by an affiliate of Japan’s Fujifilm Holdings Corp. has been confirmed by clinical tests to be effective in treating patients with COVID-19, caused by the new coronavirus, China’s science and technology ministry has said.

In the clinical tests at hospitals in Wuhan, Hubei Province, and Shenzhen, Guangdong Province, patients given the drug were quicker to turn negative for the coronavirus and see their pneumonia symptoms improve, according to the Chinese ministry.

In Japan, the administration of Avigan to treat COVID-19 patients started last month.

Major Chinese drug maker Zhejiang Hisun Pharmaceutical Co. plans to produce a generic drug of Avigan, based on a license agreement it concluded with Fujifilm in 2016.

JIJI Press

return to top